Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Top
Argentina
Bangladesh
Belize
Bolivia
Botswana
Brazil
Bulgaria
Cambodia
Colombia
Czechia
Dominican Repu..
Ecuador
Egypt
El Salvador
Germany
Guatemala
Honduras
India
Indonesia
Iran
Jamaica
Japan
Lebanon
Malaysia
Mexico
Nicaragua
Nigeria
North Macedonia
Panama
Paraguay
Peru
Philippines
Portugal
Slovakia
Thailand
USA
Ukraine
Venezuela
Zimbabwe

Feedback
Home   COVID-19 treatment studies  COVID-19 treatment studies  COVID-19 studies   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
Global ivermectin adoption for COVID-19: 44%
Download Image
IVERMECTIN ADOPTION MINIMAL COVID-19 ISOLATED USE SOME REGIONS MIXED USAGE MANY REGIONS COUNTRY-WIDE ADOPTION AS OF OCT 2022 - SUBMIT CORRECTIONS - IVMSTATUS.COM MINIMAL COVID-19: 3.0B ISOLATED USE: 310M COUNTRY-WIDE: 394M MIXED USAGE: 618M SOME REGIONS: 720M MANY REGIONS: 1.6B TOTAL COVERED: 2.1B WORLD COVERED: 27% COVID COVERED: 44%
Ivermectin is currently used for about 27% of the world's population. Countries where COVID-19 mortality is close to zero may not have incentive to adopt treatments. When excluding these countries, ivermectin adoption is about 44%. We excluded countries where the cumulative mortality over the preceding month was less than 1 in 1 million, according to the data at https://ourworldindata.org/). For the estimated population coverage, isolated use, some regions, mixed usage, and many regions use a factor of 0.05, 0.25, 0.5, and 0.75 respectively. Please send us corrections/updates.
References
Argentina - mixed usage - Jan 26, 2021
Bangladesh - country-wide adoption
Belize - country-wide adoption - used for serious cases - Dec 18, 2020
Bolivia - country-wide adoption
Botswana - mixed usage
Brazil - used in some regions - Jan 26, 2021
Bulgaria - country-wide adoption
Cambodia - country-wide adoption
Colombia - used in many regions
Czechia - isolated use - authorized, but reportedly almost no use
Dominican Republic - country-wide adoption - Sep 30, 2020
Ecuador - mixed usage
Egypt - country-wide adoption - Nov 30, 2020
El Salvador - country-wide adoption
Germany - isolated use - Dec 31, 2020
Guatemala - country-wide adoption - Jan 23, 2021
Honduras - country-wide adoption - Apr 23, 2020
India - used in many regions
Indonesia - mixed usage
Iran - mixed usage - now manufacturing their own ivermectin, but the level of usage is unclear
Jamaica - isolated use - authorized for off-label use, availability delayed
Japan - used in some regions - May 18, 2020
Lebanon - country-wide adoption - Jan 27, 2021
Malaysia - isolated use
Mexico - mixed usage - Dec 29, 2020
Nicaragua - country-wide adoption - Jan 25, 2021
Nigeria - used in many regions
North Macedonia - mixed usage - Jan 15, 2021
Panama - country-wide adoption
Paraguay - used in some regions
Peru - used in some regions - was widely used but later restricted, a study shows 14x reduction in excess deaths when used and 13x increase when restricted - May 8, 2020
Philippines - isolated use
Portugal - used in some regions
Slovakia - mixed usage - while approved, press has been divided, censorship is common, and access is limited but improving - Jan 27, 2021
Thailand - isolated use
USA - used in some regions - Oct 31, 2020
Ukraine - mixed usage
Venezuela - country-wide adoption
Zimbabwe - mixed usage - Jan 28, 2021
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit